Xylometazoline (HCl)

Overview
Chemically Xylometazoline (HCl) is 2-(4-tert-butyl-2, 6-dimethylbenzyl)-2-imidazoline.
Xylometazoline (HCl) is a direct acting alpha-adrenoceptor agonist, used as vasoconstrictor for nasal
decongestion. It promotes nasal drainage and relieves nasal stuffiness. Xylometazoline (HCl) is
used to relieve symptoms associated with a cold, hay fever, allergies, sinus infections and other
related conditions.

Categories
 25 Drugs acting on the respiratory tract
o 25.4 Nasal preparations

Page headings
OverviewPrimary CharactersticsIndicationsPharmacokineticsContraindicationsDrug InteractionsSide
EffectsDosageHigh Risk GroupsWarning / PrecautionsStorage ConditionsInterference in
PathologyBrands of Xylometazoline (HCl)Manufacturers of Xylometazoline (HCl)

Primary Characterstics
Xylometazoline is the derivative of Xylometazoline (HCl)Xylometazoline is the derivative of
Xylometazoline (HCl) It is of Synthetic origin and belongs to Imidazole. It belongs to Alpha-2
adrenergic agonist pharmacological group on the basis of mechanism of action and also classified in
Nasal Decongestants and Opthalmic Agent, Vasoconstrictor pharmacological group.The Molecular
Weight of Xylometazoline (HCl) is 280.80.
It is weakly acidic drug, 4.68% solution of the drug is isotonic.

Indications
Xylometazoline (HCl) is primarily indicated in conditions like Allergic conjunctivitis, Allergic
rhinitis, Eye inflammation, Nasal congestion, Ocular congestion, Otitis media, Sinusitis.
Back to top

Pharmacokinetics
Back to top

Contraindications
Xylometazoline (HCl) is contraindicated in conditions like Diabetes mellitus, Hypertension, Narrow-
angle glaucoma, Vasomotor rhinitis, Atrophic rhinitis.
Back to top

Drug Interactions
No data regarding the interactions of Xylometazoline (HCl) was found.
Back to top

Side Effects
The severe or irreversible adverse effects of Xylometazoline (HCl), which give rise to further
complications include Rhinitis medicamentosa.
The symptomatic adverse reactions produced by Xylometazoline (HCl) are more or less tolerable
and if they become severe, they can be treated symptomatically, these include Headache, Stinging
on application, Dryness of eye, Dryness of nose.
Back to top

Dosage
Xylometazoline (HCl)'s dosage details are as follows:
Dose Single Dose Frequency Route Instructions

Adult Dosage
0.1 % 0.1 (0.1) 8 hourly Intra Nasal 2-3 drops in each nostril.

Paedriatic Dosage (20kg)

0.1 to 0.15 mg 0.12 (0.125) 8 hourly Opthalmic -

Neonatal Dosage (3kg)

Not recommended in this age group

High Risk Groups

Drug should not be given to Paediatrics, Neonates, and Pregnant Mothers.

If prescribing authority justifies the benefits of the drug against the possible damages he/she should
reevaluate them and consult the reference material and previous studies.
Back to top

Warning / Precautions
Use topical decongestant (xylometazoline) only in acute conditions, not longer than 3 to 5 days. It
should be used sparingly in all patients, especially in infants, children and in cardiac patients.

Back to top

Storage Conditions
Nasal Spray
Store Below 40°C. Do not Freeze.
Back to top

Interference in Pathology
No data regarding the pathological interferences produced by Xylometazoline (HCl) is available.
Back to top

Brands / Trade Names of Xylometazoline (HCl)

Click on the desired strength of the dosage form to view its available brands.

Single Ingredient
Nasal Drops: 5 ml, 0.05 %w/v,
Nasal Spray: 0.1 %w/v,

Multi ingredient
Nasal Spray: 0.025 %w/v,
Back to top